Clinical Trial Update: A Pharmacodynamic Study With Ticagrelor in African American Patients [Phase 4]

View source ↗

Summary

Phase 4 pharmacodynamic study of ticagrelor in African American patients with stable coronary artery disease has completed and the results have been posted. The…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Stable Coronary Artery Disease

Drugs mentioned

• ticagrelor (Brilinta) (ticagrelor)

Snippet

Sponsor: AstraZeneca | Conditions: Stable Coronary Artery Disease | Phase 4 | Status: COMPLETED | Results posted: 2014-09-26